Published Date: 02 Mar 2023
A study recently published in the American Journal of Clinical Nutrition (AJCN) investigated the role of omega-3 fatty acids, specifically EPA and DHA, and whether they can prevent poor and/or negative weight loss. .
Read Full NewsResearchers increasingly suggest that biological diversity within schizophrenia may limit efforts to identify a single defining biomarker.
Research shows that snus and newer oral nicotine pouches are associated with localized soft tissue changes, prompting greater attention to their oral health effects.
1.
Cabozantinib Improves PFS for Advanced Neuroendocrine Tumors
2.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
3.
Do I qualify for a cancer clinical trial?
4.
'It's rare and it's scary.' Dark spot on your fingernail could mean cancer
5.
When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.
1.
Unlocking the Potential of Etoposide: A Novel Approach to Cancer Treatment
2.
MMA Embolization in Chronic Subdural Hematoma: Evidence, Outcomes, and Gaps
3.
Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment
4.
Cancer Rates on the Rise: What Can We Do to Stop It?
5.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
5.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation